Article
PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.
BMC cancer - 17 Dec 2013
Chiosea Simion I, Grandis Jennifer R, Lui Vivian W Y, Diergaarde Brenda, Maxwell Jessica H, Ferris Robert L, Kim Seungwon W, Luvison Alyssa, Miller Megan, Nikiforova Marina N
Abstract excerpt
BACKGROUND: Recent genomic evidence suggests frequent phosphatidylinositide 3-kinase (PI3K) pathway activation in human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. Mutations/amplification of the gene encoding p110α catalytic subunit of phosphoinositide 3-kinase (PIK3CA), loss of phosphatase and tensin homolog (PTEN) and HRAS mutations are known to activate PI3K pathway. METHODS AND...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
